Search

Phage DNA Extraction

PhageDNA Extraction

Creative Biolabs provides phage DNA extraction tailored to the starting lysate and downstream application, with host-nucleic-acid reduction, genome recovery, purification, and fit-for-purpose QC.

Explore Service DetailsDiscuss Your Project

Service Overview

Phage DNA extraction is more than a cleanup step when the purified genome will feed sequencing, PCR, restriction analysis, cloning, or other molecular work. Phage lysates may contain intact virions together with bacterial DNA and RNA, proteins, cell debris, salts, medium components, and free nucleases. Where particle integrity allows, exposed host nucleic acids are reduced before capsid disruption, followed by genome release and purification. This sequence helps control host background while protecting the encapsidated phage genome.

The extraction plan is matched to the sample and downstream use. Particle stability, genome type, lysate clarity, starting abundance, and storage history can all affect recovery. Standard column workflows suit many DNA phages, while ssDNA, unusual termini, modified bases, or protein-linked genomes may require a different strategy. For projects continuing into phage DNA characterization or phage genome sequencing, we set extraction and QC priorities with the next assay in mind.

Phage DNA Extraction Workflow. (Creative Biolabs Authorized)

Choose the Right Phage DNA Service

Start with the question the project needs to answer. Extraction prepares purified genomic DNA, while characterization, sequencing, annotation, and comparative analysis address different downstream needs.

Choose the Right Phage DNA Service comparison table
Research NeedRecommended RouteWhat It Answers
Purified phage genomic DNAPhage DNA ExtractionPrepare DNA for downstream molecular analysis
DNA size, integrity, or molecular propertiesPhage DNA CharacterizationExamine extracted phage DNA
Complete genome sequencePhage Genome SequencingDetermine genomic sequence
Functional genome featuresPhage Genome AnnotationInterpret genes and genomic features
Cross-phage genomic comparisonComparative Genomic AnalysisCompare genome organization and relationships

Phage DNA Extraction Service Design

The extraction strategy is set by the condition of the lysate and the quality requirements of the next assay. If starting abundance is uncertain, an independent phage titer test can help estimate infectious particles; phage nucleic acid and protein detection addresses a different analytical question. Neither replaces extraction-specific QC.

  • Phage abundance. Starting particle abundance sets the approximate genome mass available for recovery, but titer does not directly predict final DNA yield because genome size and processing losses also matter.
  • Lysate condition. Cellular debris, free host DNA, proteins, and medium components can increase viscosity, column loading, and contaminant carryover.
  • Particle integrity. Host-nucleic-acid depletion before capsid disruption depends on the genome remaining protected inside intact particles. Damaged particles call for more cautious nuclease handling.
  • Genome type and chemistry. Known dsDNA, ssDNA, unusual termini, modified bases, or genome-linked proteins may affect extraction chemistry, enzymatic processing, and later library preparation.
  • Storage and handling. Repeated freeze-thaw cycles, extended storage, or harsh handling can compromise particle integrity or fragment released DNA.
  • Downstream application. Short-read sequencing, long-read sequencing, PCR, restriction analysis, and cloning place different priorities on DNA integrity, inhibitor removal, and concentration.

DNA Quality Assessment for Downstream Use

DNA concentration alone does not establish downstream suitability. Concentration, purity indicators, and integrity are interpreted together and against the requirements of the planned assay. Residual RNA can inflate apparent nucleic-acid concentration, while salts, proteins, chaotropic agents, or other inhibitors may affect enzymatic workflows without an obvious concentration warning.

  • Concentration. Is enough recoverable DNA available for the planned assay?
  • Purity indicators. Do the measurements suggest residual RNA, protein, salts, or other contaminants?
  • Integrity. Is the DNA sufficiently intact for the intended PCR, restriction, cloning, or sequencing workflow?
  • Downstream compatibility. Does the preparation meet the practical requirements of the next analytical step?

For sequencing projects, host-DNA carryover may become apparent only during library preparation or read analysis, so upstream background reduction remains important even when absorbance measurements look clean. When broader DNA-level interpretation is needed, the purified material can continue into phage DNA analysis.

Optional Downstream Phage DNA Analysis

When the project extends beyond extraction, the same DNA can continue into Phage DNA Characterization for molecular assessment, Phage Genome Sequencing for sequence generation, Phage Genome Annotation for gene-level interpretation, or Comparative Genomic Analysis when relationships among multiple phages are the research focus. Planning the next step before extraction helps set the right integrity and contaminant priorities from the beginning.

Our Phage DNA Extraction Workflow

Fig.1 Workflow of phage DNA extraction service, including sample review, host nucleic acid removal, DNA release, DNA purification, and DNA quantification. (Creative Biolabs Original)
Fig.1 Workflow of phage DNA extraction service.

The workflow is adapted to the phage, lysate condition, and intended downstream application.

  1. 01

    Sample Review

    Assess the submitted phage lysate, including sample history, available titer or concentration data, propagation host, known genome features, and downstream requirements.

  2. 02

    Host Nucleic Acid Removal

    Reduce accessible bacterial DNA and RNA while phage particles remain intact, where sample condition and particle integrity permit.

  3. 03

    DNA Release

    Disrupt the phage particles and release genomic DNA using conditions selected for the phage and genome type.

  4. 04

    DNA Purification

    Remove proteins, residual nucleic acids, salts, and other contaminants to obtain purified phage genomic DNA suitable for downstream analysis.

  5. 05

    DNA Quantification

    Measure DNA concentration and assess agreed quality parameters before delivering the purified DNA or proceeding to downstream molecular analysis.

Project Inputs and Deliverables

Project Inputs

What to Send Us

  • Sample.

    Phage identity or family if known, propagation host, lysate volume, and available titer or concentration data. Reference titer ≥ 5 × 109 pfu/mL (please provide titer data if available).

  • Genome context.

    Known genome type, unusual termini, modified bases, genome-linked proteins, or other relevant features if available.

  • Handling history.

    Purification history, storage conditions, and any repeated freeze-thaw or other handling concerns.

  • Downstream goal.

    Planned sequencing, PCR, restriction analysis, cloning, or other molecular use, including any prior assay failure that may inform troubleshooting.

Project Outputs

What You Receive

  • Purified phage genomic DNA.

    Material prepared for the agreed downstream use.

  • DNA QC results.

    Agreed concentration, purity, and integrity measurements.

  • Downstream suitability.

    Quality findings interpreted against the requirements defined for the project.

  • Technical record.

    An extraction record or technical report documenting the agreed workflow and QC results.

Exact material, QC depth, and acceptance criteria are defined from the starting lysate and downstream method rather than a single fixed yield or purity threshold for every phage type.

Published Data

Agarose gel showing intact genomic DNA recovered from four bacteriophage preparations after nuclease pretreatment, capsid digestion, and spin-column purification, with a 1 kb DNA ladder for size reference (OA Literature)
Fig.2 Agarose-gel assessment of purified bacteriophage genomic DNA.1

Jakočiūnė and Moodley described a rapid dsDNA bacteriophage extraction workflow in which accessible bacterial nucleic acids were removed before capsid disruption and silica-column purification. Filtered phage lysates were treated with DNase I and RNase A, followed by proteinase K digestion and spin-column purification. Recovered DNA was assessed by spectrophotometry, fluorometry, and agarose gel electrophoresis and used for Illumina MiSeq library preparation and whole-genome sequencing. Figure 2 shows intact DNA bands from four phage preparations, illustrating how genome integrity can be checked after purification. The study supports treating host-background reduction, particle disruption, purification, and DNA QC as linked steps, while not implying a universal yield threshold or a single protocol for ssDNA, modified, or otherwise unusual phage genomes.

Frequently Asked Questions

Can crude bacterial culture be used directly for phage DNA extraction?
Usually some clarification is required because cell debris and host nucleic acids can dominate the preparation. The extent of cleanup depends on how the phage was propagated and what the purified DNA will be used for.
Why can nuclease treatment be performed before phage particles are opened?
When virions are intact, the phage genome remains physically protected while exposed bacterial DNA and RNA are accessible to nuclease treatment. This approach is appropriate only when particle integrity is adequate and the genome is not already exposed.
Does a good A260/A280 ratio prove that phage DNA is sequencing ready?
No. It is one quality indicator. DNA integrity, concentration, host-DNA carryover, residual inhibitors, and the requirements of the sequencing library method also matter.
Can the same extraction method be used for every bacteriophage?
No. Genome type, particle stability, terminal structures, modified bases, sample matrix, and downstream use can all change the preferred preparation strategy.
Should phage DNA extraction be ordered separately from genome sequencing?
It can be, but the two steps are often easier to plan together. When sequencing is the final objective, extraction and QC can be tailored to the selected sequencing route from the start.
What happens if DNA recovery is low?
Recovery depends on starting abundance, lysate quality, particle integrity, genome size, handling history, and losses during cleanup. Available titer and sample metadata help distinguish low biological input from losses during purification.

Reference

1. Jakočiūnė, Džiuginta, and Arshnee Moodley. A Rapid Bacteriophage DNA Extraction Method. Methods and Protocols 1.3 (2018): article 27. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.3390/mps1030027.

×
Online Inquiry

Please kindly note that our services can only be used to support research purposes (Not for clinical use).

Biophage Technology

Creative Biolabs is a globally recognized phage company. Creative Biolabs is committed to providing researchers with the most reliable service and the most competitive price.

Contact Us
  • Global Locations
Privacy Policy | Cookie Policy | Copyright © 2026 Creative Biolabs. All rights reserved.